Answers are grounded in this paper and cite their sources.
Retrospective cohort study shows elevated liver and cardiovascular risks in metabolic dysfunction-associated steatohepatitis, indicating urgent need for management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gbadamosi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: